Family: | ProShares |
Name: | ProShares Ultra Nasdaq Biotechnology |
Inception Date: | 7-Apr-2010 |
Termination Date: | |
Investment Objective: | ProShares Ultra Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the daily performance of the NASDAQ Biotechnology Index. |
Prospectus | |
Top 10 Holdings | ||
Derivatives offset | -125.5251% | |
NASDAQ Bio Index SWAP BNP | 42.2824% | |
NASDAQ Biotechnology Index SWAP UBS AG | 37.4213% | |
TREASURY BILL | 912797GK7 | 18.9373% |
NASDAQ Biotechnology Index SWAP Bank of America NA | 17.3522% | |
NASDAQ Biotechnology Index SWAP Societe Generale | 12.6160% | |
NASDAQ Biotechnology Index SWAP Goldman Sachs International | 6.8753% | |
Net Other Assets (Liabilities) | 6.4817% | |
AMGEN INC | AMGN | 6.3331% |
VERTEX PHARMACEUTICALS INC | VRTX | 6.1726% |
Top 10 Holdings Weight: | 28.9% |
Number of Holdings: | 230 |
Shares Outstanding: | 1,625,000 |
Total Net Assets: | 78,016,250 |
NAV: | 47.96 |
Net Expense Ratio: | 0.95% |
Asset Class: | Equities (Stocks) |
Developed or Emerging: | Developed Market Funds |
Country: | US |
Region: | |
Strategy: | |
Currency: | |
Commodity: | |
Sector: | Healthcare |
Industry: | Biotech |
Dividend Type: | |
Tax Exempt State: | |
Maturity Duration: | |
Market Cap: | Broad Market / Multi-Cap |
Credit Quality: | |
Mortgage Bond Types: | |
Bond Type: | |
Gov't Bond Types: | |
Reit Type: | |
Leverage Direction/Factor: | Leveraged (2x) |
Is Currency Hedged: | No |
US or Ex-US: | Domestic |